1
A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC
Condition(s):Squamous Cell Carcinoma of the OropharynxLast Updated:January 16, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Squamous Cell Carcinoma of the OropharynxLast Updated:January 16, 2024Active, not recruiting
Condition(s):Squamous Cell Carcinoma of the Oropharynx; HPV16 PositiveLast Updated:December 29, 2023Active, not recruiting
Condition(s):Cervical CancerLast Updated:March 6, 2019Completed
Condition(s):HPV-Related Squamous Cell Carcinoma; Head and Neck Squamous Cell CarcinomaLast Updated:September 7, 2023Recruiting
Condition(s):Tumors or Premalignant LesionsLast Updated:February 21, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.